Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.

• Main Authors: Sammy M Njenga (Author), Henry Kanyi (Author), Collins Okoyo (Author), Edward Githinji (Author), Cassian Mwatele (Author), Sultani H Matendechero (Author), Wyckliff P Omondi (Author), Patrick N Gitahi (Author), Chrispin Owaga (Author), Joyce K Onsongo (Author), Katherine Gass (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2024-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The World Health Organization (WHO) endorsed the use of triple-drug mass drug administration (MDA) regimen with ivermectin, diethylcarbamazine (DEC) and albendazole (commonly abbreviated as IDA) to accelerate the elimination of lymphatic filariasis (LF) as a public health problem in settings where o...